Pharmaceutical Fluid Handling Market Statistics Report 2028

The pharmaceutical fluid handling market is projected to reach US$ 14,209.40 million by 2028 from US$ 10,302.78 million in 2021; it is estimated to register a CAGR of 4.7% from 2022 to 2028.

Pharmaceutical fluid handling is an integral part of pharmaceutical industry to ensure that fluids such as cough syrups, intravenous products, and complex active pharmaceutical ingredients are delivered in a safe and timely manner. To succeed and be reliable, businesses need to utilize the correct handling equipment and instruments. The manufacturing divisions in the biotechnology and pharmaceutical industry require fluid control systems since their most processes involve liquid such as feed media, buffer solutions, cell extracts, and product fractions.

The pharmaceutical fluid handling market is segmented based on offering, tubing, application, usage, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.  

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Pharmaceutical Fluid Handling Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Rise in Adoption of Single-Use Systems (SUS) in the Pharmaceutical Industry

In pharmaceutical and biopharmaceutical product manufacturing, contamination prevention is a crucial part of the process. The proper handling and storage of fluids are essential to limit the possibility of contamination. Facility layout helps determine the method used by companies to handle fluid transfer and storage. The growing adoption of single-use systems (SUS) reduces product cross-contamination and eliminates the need for cleaning between batches, hence improving efficiency. The SUSs are made in a cleanroom; they are double bagged, and gamma, ethylene oxide, or x-ray methods are used to ensure a sterile system for every batch.

During the development of several pharmaceutical products such as vaccines, monoclonal antibodies, and personalized medicines, SUS is used as it offers a faster, simpler, and less expensive manufacturing process. Due to the rising prevalence of chronic diseases, there is a growing demand for effective drugs and products. Hence, companies are increasingly opting for SUS because it enhances the efficiency of processes and reduces costs related to cleaning, sterilization, and maintenance. In addition, low risk of contamination and low water consumption are a few factors supporting the pharmaceutical fluid handling market growth. The market growth is also attributed to increased company activities and rapid adoption of various business strategies such as collaborations, partnerships, and product launches. For instance, in April 2022, Merck signed an agreement with Wuxi National High-Tech Industrial Development Zone to expand its first Asia Pacific Mobius Single-Use manufacturing center.

Thus, the increased use of SUS in the production and transfer of sterile fluids is driving the growth of the pharmaceutical fluid handling market.

Increase in Vaccine Production

Vaccines strengthen the immune system of different age groups, providing protection against infectious diseases. In the past few decades, effective immunization has eliminated polio and smallpox, which registered high mortality rates. In recent years, there has been an increase in vaccination demand due to the rising incidences of viral and bacterial infectious diseases. Further, government foundations, hospitals, and pharmaceutical companies are focusing on regular vaccine administration by providing cost-effective immunization globally. This is boosting the demand for vaccine production, which is likely to promote the growth of the pharmaceutical fluid handling market. For instance, the Indian Universal Immunization Programme (UPI) rolled out its pneumococcal conjugate vaccine to 21 lakh children. Additionally, government funding and company investments are stimulating R&D to launch new products. According to World Health Organization, in November 2022, a total of 16 billion vaccine doses, valued at US$ 141 billion, were supplied in 2021, which is approximately three times more than the doses supplied in 2019, i.e., 5.8 billion. The Serum Institute of India (SII) postponed HPV vaccine production for two years due to the focus on the development of COVID-19 vaccines; however, it will begin supplying HPV vaccine to the Government of India by 2023 in small quantities. Thus, an increase in vaccine production is anticipated to create an opportunity for the pharmaceutical fluid handling market during the forecast period.

Tubing-Based Insights

Based on tubing, the global pharmaceutical fluid handling market is segmented into thermoplastic elastomers (TPE), polyvinyl chloride (PVC), and silicone. In 2022, the silicone segment held the largest share of the market. The TPE segment is expected to grow at the highest CAGR during 2022–2028. Thermoplastic elastomers (TPEs) offer excellent processability, making them suitable for all conventional extrusion plants and injection molding. They are cost-effective and have lower emissions and reliable reusability. High-quality, specialized tubing is vital to design a system of efficient pharmaceutical fluid processing; the pre-sterilized tubing is required to meet specific manufacturing standards, and sterilization capability is necessary when the tubing is exposed to autoclaving, gas treatment, gamma irradiation, and other sterilization methods.  A significant consideration for biopharmaceutical tubing is its welding and sealing capability; TPEs can be welded and heat-sealed. For example, on May 18, 2022, Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, launched HelixFlex, which combines all benefits, i.e., weldable, translucent, sealable, and can be used in peristaltic pumping applications. A high-purity thermoplastic elastomer TPE tubing is designed for biopharmaceutical and pharmaceutical applications.

Application-Based Insights

Based on application, the pharmaceutical fluid handling market is segmented into fluid handling & management, fluid preparation, integration & automation, aseptic processing, buffer management, and others. The fluid handling & management segment held the largest market share in 2021; however, the integration & automation segment is further expected to be the largest shareholder in the market by 2028. Automation is inevitable and ever expansive. As technology continues to advance, automation shows the potential to transform processes and introduce performance improvements. In the pharmaceutical industry, the use of automation also reduces the chance of human error through its capability to consistently perform repetitive tasks. Pharmaceutical companies have been integrating automation into specific processes such as drug development, serialization, and anti-counterfeiting. In manufacturing examples, automation has become prevalent in processes such as fluid handling and management. Automation is essential for in vitro diagnostics (IVD), molecular analysis, flow cytometry, next-generation sequencing (NGS), or cell biology systems. Furthermore, combining mixing technology with filtration and fluid management permits the automated preparation of fluids using standard recipes to mix, adjust pH, and filter process buffers. Thus, growing demand for automaton is expected to drive the market for pharmaceutical fluid handling in the coming years.

Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global pharmaceutical fluid handling market. A few of the recent key product developments are listed below:

• In October 2022, Merck, a leading science and technology company, opened a commercial facility for its new Millipore CTDMO Services offering at the company’s site in Martillac, France.
• In July 2022, A&G AS, based in the Estonian capital of Tallinn, has been part of the Raumedic group of companies since 2021. The company specializes in assembly in the field of medical technology and is equipped with corresponding cleanroom production space.

The COVID-19 pandemic disrupted everyday lives of people and businesses worldwide, and the pharmaceutical supply chain was greatly affected. The COVID-19 pandemic inflicted enormous pressure on healthcare infrastructure and hampered the operational capabilities of the biopharmaceutical companies and clinical laboratories. The COVID-19 pandemic led to a significant increase in industry growth, as pharmaceutical liquid handling was in high demand, as specimens had to be processed faster in the laboratory to conduct research on the COVID-19 virus. The COVID-19 vaccine development boosted the need for advanced automated liquid handling systems. As a result of the outbreak of COVID-19, the market has grown positively.

Pharmaceutical Fluid Handling Market Regional Insights

The regional trends and factors influencing the Pharmaceutical Fluid Handling Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pharmaceutical Fluid Handling Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Pharmaceutical Fluid Handling Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Pharmaceutical Fluid Handling Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Pharmaceutical Fluid Handling Market are:

1. CIRCOR Internatioonal Inc
2. Parker Hannifin Corp
3. Danaher Corp
4. Spirax Sarco Engineering plc
5. Merck KGaA

Disclaimer: The companies listed above are not ranked in any particular order.

Pharmaceutical Fluid Handling – Market Segmentation

Based on offering, the market is segmented into equipment & solutions and services. The equipment & solutions is further segmented into metering pumps and capsule equipment (filling/sorting), mixing equipment and valves, thermal processing equipment (coolers/chillers/dryers/heat-exchangers), x-ray inspection systems, tanks for holding liquids and flow control products, filters/filter sets (pre-filters/ sterilizing grade filters/ virus filters), powder handling bags, sterile connectors/disconnectors and membrane filter cartridges, and others. Based on tubing, the market is segmented into TPE, PVC, and Silicone. Based on application, the market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. The fluid handling and management segment is further segmented into single-use systems and multi-use systems, bioprocessing workstations, standard storage systems and biocontainers, totes, and others. Based on usage, the market is segmented into cough syrup, intravenous products, complex APIs, and others. The complex APIs segment is further categorized into vaccines, medication for cancer treatments, and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical and medical companies, and others. Based on geography, the market is divided into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

• CIRCOR International Inc
• Parker Hannifin Corp
• Danaher Corp
• Spirax Sarco Engineering plc
• Merck KGaA
• Rochling SE & Co KG
• RAUMEDIC AG
• Tef Cap Industries Inc
• Fraser Ross Ltd
• Australian Fluid Handling Pty Ltd